Good morning, everyone, and welcome to IMI's 2025 Full Year Results Presentation. I am joined here today by our CFO, Luke Grant. Together, we will take you through another year of strong strategic and ...
Welcome to Endeavour Mining's Fourth Quarter and Full Year 2025 Results Webcast. [Operator Instructions] Today's conference call is being recorded, and a transcript of the call will be available on ...
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; ...
Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics Olga Anczukow, Ph.D. Olga Anczukow, Ph.D.
Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics ...
Remuneration Policy adopted by the Annual General Meeting of TORM plc on 14 April 2021, the Board of Directors has as part of a long-term incentive program decided to grant certain employees (the ...
Hosted on MSN
Basic vs advanced English showdown
Basic vs advanced English showdown 🔥!! RCMP reveal gun details in Tumbler Ridge, BC., mass killing Something is happening with orcas at sea - The attacks are spreading Sugary sodas cause deadly ...
Swiss Aerospace manufacturer, Pilatus Aircraft Ltd, selects RDU-3068 as PFD/MFD for its basic training aircraft This ...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2025 and ...
Operational penetration testing is a process of simulating real-world attacks on OT systems to identify vulnerabilities before cybercriminals can exploit them, either physically or remotely. OT ...
Farm management analyst Kent Thiesse answers some of the farm program and crop insurance questions that have resulted from the implementation of the One Big Beautiful Bill Act. Some of the farm ...
Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected mid-2026Global pivotal Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results